Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic Radiotherapy

NCT02649491 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT02649491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02649491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic Radiotherapy
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2015
Completion date
October 31, 2019
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, malignancy, toxicity